Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:

Clinical trial transparency – TINZ influencing for positive change– Transparency International New Zealand

Transparency International New Zealand (TINZ) and Mesh Down Under advocated the Ministry of Health and Health Research Council to sign the World Health Organization (WHO) joint statement on public disclosure of clinical trial results. The joint statement requires signatories to mandate time frames for public disclosure and monitor registration, among other things.

Read the full story on Transparency International New Zealand here

New PRS guided tutorials – recently launched a new tool to help guide PRS users to enter their results information. A beta version is located on the website and a feedback quiz is available to further develop the content.

Follow the news updates from

Research transparency and me: a blog by patient advocate Margaret Grayson – NHS Health Research Authority

Diagnosed with breast cancer in 2004, retired radiographer Margaret Grayson has become a patient advocate. She discusses why transparency in clinical research is very important to her.

Read about Margaret’s experience here

 A perfect score – Johns Hopkins Institute for Clinical and Translational Research

Johns Hopkins University recently announced that it has achieved 100% compliance with a federal law designed to reveal clinical trial results. This is a notable achievement, as Johns Hopkins University has become one of the first academic medical centers in the U.S. to fully comply with this law.

Catch up on the latest news from Johns Hopkins

Workshop alert: Enhancing scientific reproducibility through transparent reporting – The National Academies of Sciences, Engineering, and Medicine

From September 25-September 26, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine is holding a public workshop to discuss transparency in reporting pre-clinical biomedical research. The workshop also plans to explore improvements for the future.

Learn more about this workshop here

< Back to Blog